Cann Group Limited (ASX:CAN)

Market Cap	9.77M
Revenue (ttm)	15.51M
Net Income (ttm)	-47.60M
Shares Out	610.60M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,991,431
Average Volume	2,024,759
Open	0.0150
Previous Close	0.0160
Day's Range	0.0150 - 0.0160
52-Week Range	0.0150 - 0.1277
Beta	1.10
RSI	39.45
Earnings Date	May 29, 2025

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CAN

Financial Performance

In 2024, Cann Group's revenue was 18.36 million, a decrease of -11.03% compared to the previous year's 20.63 million. Losses were -51.24 million, 51.6% more than in 2023.